Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488, 62531-62532 [2012-25162]

Download as PDF Federal Register / Vol. 77, No. 199 / Monday, October 15, 2012 / Notices Number of annual respondents Average time per response 62531 Total annual hours DEA–224 (paper) .......................................................... DEA–224 (electronic) ................................................... DEA–224a (paper) ........................................................ DEA–224a (electronic ................................................... DEA–224b (chain renewal)* ......................................... DEA–224c ............................................................. 5,867 79,057 66,200 323,758 32 0 0.2 hours (12 minutes) ................................................. 0.13 hours (8 minutes) ................................................. 0.2 hours (12 minutes) ................................................. 0.07 hours (4 minutes) ................................................. 5 hours .......................................................................... 0.25 hours (15 minutes) ............................................... 1,173.4 10,540.9 13,240 21,583.8 160 0 Total .............................................................................. 474,914 ....................................................................................... 46,698.1 * In total, 64 chain pharmacies represent 36,660 individual pharmacy registrants. Pharmacies register for a three-year registration period. In calendar year 2011, the year for which estimates are calculated, 32 chains registered 6,472 individual pharmacies. (6) An estimate of the total public burden (in hours) associated with the collection: It is estimated that there are 46,698 annual burden hours associated with this information collection. If additional information is required contact: Jerri Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, Department of Justice, Two Constitution Square, 145 N Street NE., Suite 2E–508, Washington, DC 20530. Dated: October 9, 2012. Jerri Murray, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. 2012–25160 Filed 10–12–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0047] Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488 erowe on DSK2VPTVN1PROD with ACTION: 30-Day Notice. The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register 77, Number 154, page 47667, on August 9, 2012, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until November 14, 2012. This process is conducted in accordance with 5 CFR 1320.10. VerDate Mar<15>2010 15:21 Oct 12, 2012 Jkt 229001 If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact John W. Partridge, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152; (202) 307–7297. Written comments concerning this information collection should be sent to the Office of Information and Regulatory Affairs, Office of Management and Budget, Attn: DOJ Desk Officer. The best way to ensure your comments are received is to email them to oira_submission@omb.eop.gov or fax them to (202) 395–7285. All comments should reference the eight-digit OMB number for the collection or the title of the collection. If you have questions concerning the collection, please contact John W. Partridge, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, (202) 307–7297, or the DOJ Desk Officer at (202) 395– 3897. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of Information Collection 1117–0047 (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine. (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: DEA form 488. Component: Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: None. Abstract: Title 21 U.S.C. 952 and 21 CFR 1315.34 require that persons who desire to import the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine during the next calendar year shall apply on DEA Form 488 for import quota for such List I chemicals. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 22 persons complete 52 DEA Forms 488 annually for this collection at 1 hour per form, for an annual burden of 52 hours. Respondents complete a separate DEA Form 488 for each List I chemical for which quota is sought. (6) An estimate of the total public burden (in hours) associated with the collection: It is estimated that there are 52 annual burden hours associated with this collection. If additional information is required contact: Jerri Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management E:\FR\FM\15OCN1.SGM 15OCN1 62532 Federal Register / Vol. 77, No. 199 / Monday, October 15, 2012 / Notices Division, Department of Justice, Two Constitution Square, 145 N Street NE., Suite 2E–508, Washington, DC 20530. Dated: October 9, 2012. Jerri Murray, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. 2012–25162 Filed 10–12–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0023] Agency Information Collection Activities; Proposed Collection; Comments Requested: Import/Export Declaration for List I and List II Chemicals; DEA Forms 486 and 486A ACTION: 30-Day Notice. erowe on DSK2VPTVN1PROD with The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register at Volume 77, Number 154, page 47666, August 9, 2012, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until November 14, 2012. This process is conducted in accordance with 5 CFR 1320.10. If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact John W. Partridge, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement VerDate Mar<15>2010 15:21 Oct 12, 2012 Jkt 229001 Administration, 8701 Morrissette Drive, Springfield, VA 22152; (202) 307–7297. Written comments concerning this information collection should be sent to the Office of Information and Regulatory Affairs, Office of Management and Budget, Attn: DOJ Desk Officer. The best way to ensure your comments are received is to email them to oira_submission@omb.eop.gov or fax them to (202) 395–7285. All comments should reference the eight-digit OMB number for the collection or the title of the collection. If you have questions concerning the collection, please contact John W. Partridge, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, (202) 307–7297, or the DOJ Desk Officer at (202) 395– 3897 or the DOJ desk officer at (202) 395–3897. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Overview of Information Collection 1117–0023 (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Import/Export Declaration for List I and List II Chemicals. (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: DEA Forms 486 and 486A. Component: Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: Not-for-profit; State, local, and tribal government. Abstract: Persons importing, exporting, and conducting international transactions with List I and List II chemicals must notify DEA of those transactions in advance of their occurrence, including information regarding the person(s) to whom the chemical will be transferred and the quantity to be transferred. Persons must also provide return declarations, confirming the date of the importation and transfer, and the amounts of the chemical transferred. For the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine, importers must report all information known to them on the chain of distribution of the chemical from the manufacturer to the importer. This information is used to prevent shipments not intended for legitimate purposes. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The below table presents information regarding the number of respondents, responses, and associated burden hours. Note that all hour calculations have been rounded up to the nearest hour. E:\FR\FM\15OCN1.SGM 15OCN1

Agencies

[Federal Register Volume 77, Number 199 (Monday, October 15, 2012)]
[Notices]
[Pages 62531-62532]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25162]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0047]


Agency Information Collection Activities; Proposed Collection; 
Comments Requested: Application for Import Quota for Ephedrine, 
Pseudoephedrine, and Phenylpropanolamine; DEA Form 488

ACTION: 30-Day Notice.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA) will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register 77, Number 154, page 
47667, on August 9, 2012, allowing for a 60 day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until November 14, 2012. This process is conducted 
in accordance with 5 CFR 1320.10.
    If you have comments, especially on the estimated public burden or 
associated response time, suggestions, or need a copy of the proposed 
information collection instrument with instructions or additional 
information, please contact John W. Partridge, Chief, Liaison and 
Policy Section, Office of Diversion Control, Drug Enforcement 
Administration, 8701 Morrissette Drive, Springfield, VA 22152; (202) 
307-7297.
    Written comments concerning this information collection should be 
sent to the Office of Information and Regulatory Affairs, Office of 
Management and Budget, Attn: DOJ Desk Officer. The best way to ensure 
your comments are received is to email them to oira_submission@omb.eop.gov or fax them to (202) 395-7285. All comments 
should reference the eight-digit OMB number for the collection or the 
title of the collection. If you have questions concerning the 
collection, please contact John W. Partridge, Chief, Liaison and Policy 
Section, Office of Diversion Control, Drug Enforcement Administration, 
8701 Morrissette Drive, Springfield, VA 22152, (202) 307-7297, or the 
DOJ Desk Officer at (202) 395-3897.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
     Evaluate the accuracy of the agencies estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses.

Overview of Information Collection 1117-0047

    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: Application for Import Quota for 
Ephedrine, Pseudoephedrine, and Phenylpropanolamine.
    (3) Agency form number, if any, and the applicable component of the 
Department sponsoring the collection:
    Form number: DEA form 488.
    Component: Office of Diversion Control, Drug Enforcement 
Administration, Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: None.
    Abstract: Title 21 U.S.C. 952 and 21 CFR 1315.34 require that 
persons who desire to import the List I chemicals ephedrine, 
pseudoephedrine, and phenylpropanolamine during the next calendar year 
shall apply on DEA Form 488 for import quota for such List I chemicals.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: It is estimated 
that 22 persons complete 52 DEA Forms 488 annually for this collection 
at 1 hour per form, for an annual burden of 52 hours. Respondents 
complete a separate DEA Form 488 for each List I chemical for which 
quota is sought.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: It is estimated that there are 52 annual burden 
hours associated with this collection. If additional information is 
required contact: Jerri Murray, Department Clearance Officer, Policy 
and Planning Staff, Justice Management

[[Page 62532]]

Division, Department of Justice, Two Constitution Square, 145 N Street 
NE., Suite 2E-508, Washington, DC 20530.

    Dated: October 9, 2012.
Jerri Murray,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. 2012-25162 Filed 10-12-12; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.